Assignee
SPEROGENIX THERAPEUTICS LTD
CN·1 granted patent·1 pending application·0 citations·filing 2020–2023
Top patents by PatentIndex Score
2 records- 0151US2025346587A1Nitrogen-containing five-membered heterocyclic derivatives as checkpoint kinase 1 inhibitor and uses thereofSPEROGENIX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0238US12428395B2Heterocyclic compounds as kinase inhibitor and uses thereofSPEROGENIX THERAPEUTICS LTD·Filed 2020·Granted Sep 30, 2025·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →